Search Results 531-540 of 19712 for Receptor

1. Mayo Clinic research suggests women over 65 be offered hereditary cancer genetic testing

   ... receptor-negative breast cancer had high-risk mutations, regardless of their age. "As 2.5% mutation frequency is often used to trigger genetic testing ...

2. Mayo Clinic discovery is first step toward new bacteria-based constipation treatment

   Bacteria can direct the colon to secrete water via tryptamine acting on a host receptor in mice. This accelerates the movement of food through the digestive ...

3. Oncoimmune Signaling and Therapeutics - Mayo Clinic Research

   In particular, genomic alterations that affect the CBM components or upstream signaling molecules that connect the CBM signalosome to the antigen receptor can ...

4. Lutetium lu 177 dotatate (intravenous route) - Mayo Clinic

   Lutetium Lu 177 dotatate injection is used to treat somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including tumors of ...

5. 17-gene signature linked to remission after triple-negative breast cancer treatment - Mayo Clinic News Network

   ... receptors for estrogen or progesterone, nor by the human epidermal growth factor receptor 2 (HER2). In contrast, other breast cancers have at least one of ...

6. Eprosartan and hydrochlorothiazide (oral route) - Side effects & dosage - Mayo Clinic

   Lowering blood pressure can reduce the risk of strokes and heart attacks. Eprosartan is an angiotensin II receptor blocker (ARB). It works by blocking a ...

7. Publications - Andrew J. Barkmeier, M.D. - Mayo Clinic

   Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor ... Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists ...

8. Publications - Anupama Ravi, M.D. - Mayo Clinic

   H influenzae LPS colocalization with Toll-like receptor 4 in eosinophilic esophagitis. J Allergy Clin Immunol Glob. 2023 Nov; 2(4):100151. Epub 2023 Jul 20 ...

9. Ratio of 25(OH)D-to-24,25(OH)2D: A new test to confirm 24-hydroxylase (CYP24A1) deficiency as the cause of hypercalcemia - Mayo Clinic

   ... receptor (VDR). Production of 1,25(OH)2D is tightly regulated through the concentrations of serum calcium, phosphorus and parathyroid hormone (PTH).

10. EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx - Mayo Clinic

    This expanded access therapeutic protocol aims to allow patients suffering from inoperable, somatostatin receptor positive, neuroendocrine tumors ...